Cargando…

In vitro chemosensitivity of head and neck cancer cell lines

BACKGROUND: Systemic treatment of head and neck squamous cell carcinoma (HNSCC) includes a variety of antineoplastic drugs. However, drug-resistance interferes with the effectiveness of chemotherapy. Preclinical testing models are needed in order to develop approaches to overcome chemoresistance. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schuler, PJ, Trellakis, S, Greve, J, Bas, M, Bergmann, C, Bölke, E, Lehnerdt, G, Mattheis, S, Albers, AE, Brandau, S, Lang, S, Whiteside, TL, Bier, H, Hoffmann, TK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458702/ https://www.ncbi.nlm.nih.gov/pubmed/20947470 http://dx.doi.org/10.1186/2047-783X-15-8-337

Ejemplares similares

Dendritic cell generation and CD4(+)CD25(HIGH)FOXP3(+ )regulatory T cells in human head and neck carcinoma during Radio-chemotherapy
por: Schuler, PJ, et al.
Publicado: (2011)

EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma
por: Schuler, Patrick J, et al.
Publicado: (2011)

Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas
por: Bergmann, Christoph, et al.
Publicado: (2011)

Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Weller, Patrick, et al.
Publicado: (2014)

Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
por: Pogorzelski, M, et al.
Publicado: (2014)

Current Advances in Robotics for Head and Neck Surgery—A Systematic Review
por: Boehm, Felix, et al.
Publicado: (2021)

Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
por: Huang, Chuan-En, et al.
Publicado: (2014)

The bidirectional tumor - mesenchymal stromal cell interaction promotes the progression of head and neck cancer
por: Kansy, Benjamin A, et al.
Publicado: (2014)

Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.
por: Boerrigter, G. H., et al.
Publicado: (1986)

The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer
por: Atiq, Saad O., et al.
Publicado: (2018)

Adenosine-producing regulatory B cells in head and neck cancer
por: Jeske, Sandra S., et al.
Publicado: (2020)

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
por: Bas, M, et al.
Publicado: (2006)

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines
por: Schnoell, Julia, et al.
Publicado: (2023)

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer
por: Schaefer, C, et al.
Publicado: (2005)

Molecular and Functional Profiles of Exosomes From HPV(+) and HPV(−) Head and Neck Cancer Cell Lines
por: Ludwig, Sonja, et al.
Publicado: (2018)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients
por: Theodoraki, M.-N., et al.
Publicado: (2021)

T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
por: Albers, A. E., et al.
Publicado: (2010)

Editorial: Advances and novel technologies in surgical instruments for the treatment of cancer
por: Schuler, P.J., et al.
Publicado: (2022)

Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma
por: Backes, Clara, et al.
Publicado: (2017)

The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN)
por: Scheckenbach, Kathrin, et al.
Publicado: (2010)

Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ ERK signaling pathways
por: Zhao, Tengda, et al.
Publicado: (2015)

Microvessel density in head and neck squamous cell carcinoma
por: Szafarowski, Tomasz, et al.
Publicado: (2018)

Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
por: Yang, Sara, et al.
Publicado: (2022)

Plasma-derived Exosomes Reverse Epithelial-to-Mesenchymal Transition after Photodynamic Therapy of Patients with Head and Neck Cancer
por: Theodoraki, Marie-Nicole, et al.
Publicado: (2018)

Association of telomerase activity with radio- and chemosensitivity of neuroblastomas
por: Wesbuer, Simone, et al.
Publicado: (2010)

Pescadillo ribosomal biogenesis factor 1 reduction suppresses tumour growth and renders chemosensitivity of head and neck squamous cell carcinoma
por: Li, Dapeng, et al.
Publicado: (2022)

Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis
por: Matuschek, Christiane, et al.
Publicado: (2018)

The total amount of fluid administered is associated with postoperative complications in head and neck cancer surgery
por: Ziegler, Andrea, et al.
Publicado: (2023)

Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck
por: Doescher, Johannes, et al.
Publicado: (2022)

Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
por: Chen, Chao, et al.
Publicado: (2011)

Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma
por: Jeske, S. S., et al.
Publicado: (2020)

A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment
por: Chen, Chao, et al.
Publicado: (2010)

Spontaneous apoptosis of circulating T-lymphocytes and its correlation to their prolactin receptor expression and prolactin plasma levels in patients with breast cancer
por: Bauernhofer, T, et al.
Publicado: (2001)

Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center
por: Vahl, Julius M., et al.
Publicado: (2021)

The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer
por: Hofmann, Linda, et al.
Publicado: (2020)

Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety
por: Qian, Xu, et al.
Publicado: (2015)

Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma
por: Knopf, Andreas, et al.
Publicado: (2021)

Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer
por: Albers, Andreas E., et al.
Publicado: (2018)

An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model
por: Oppel, Felix, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2h83k17jgbddj3gdvr7n09b54d